Investor Presentations

Global Health Limited (ASX: GLH) is pleased to advise that its Global Health Limited Half Year 2026 Results Update for Investors has been lodged on the ASX and is now available for review.   Key Highlights: Annual Recurring Revenue (ARR) now represents 92% of customer revenue Profitable operations (before...

Last week, Global Health Limited (ASX: GLH) Managing Director, Mathew Cherian, presented at the Coffee Microcaps webinar, providing a comprehensive update on the Company’s performance, priorities, and market outlook. View the full presentation here: Sept-25 Investor Market Update. Company Snapshot: Global Health continues to deliver on its vision...

  We recently hosted an insightful webinar in partnership with Sharewise, where our Managing Director, Mathew Cherian, provided a comprehensive market update on Global Health Limited (ASX:GLH). The session covered our strategic vision, future growth plans, and key initiatives aimed at driving our success in the...

Global Health Limited is pleased to present our full year-2022 annual report and business update. Financial highlights A year of investment, following a capital raising, has delivered a material increase in sales, marketing and software development capability. Reduced professional service revenue in FY22 impacted the top line,...

Michael Davies, CEO of Global Health caught up with Ky Chow from Proactive Investors to discuss the company's latest 4C Quarterly results. Michael discusses the growth in our sales pipeline, the steps we are taking to re-platform and revolutionise our R&D, our successful implementation of MasterCare...

Watch the video.   Listen to CEO Michael Davies as he provides an update six months into his new role. Learn how Michael is leading the team, leveraging sales and marketing capabilities, investing in research and development, and positioning our product portfolio for growth. The update includes information...